Cellectis S.A.CLLSNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | 4.29% |
| Q2 2025 | 5.23% |
| Q1 2025 | 5.11% |
| Q4 2024 | -12.43% |
| Q3 2024 | 1.32% |
| Q2 2024 | 5.35% |
| Q1 2024 | -12.55% |
| Q4 2023 | 33.82% |
| Q3 2023 | -13.86% |
| Q2 2023 | 5.04% |
| Q1 2023 | 71.29% |
| Q4 2022 | -48.37% |
| Q3 2022 | -7.00% |
| Q2 2022 | -3.65% |
| Q1 2022 | -17.81% |
| Q4 2021 | -5.70% |
| Q3 2021 | 10.20% |
| Q2 2021 | 0.46% |
| Q1 2021 | 32.75% |
| Q4 2020 | 16.18% |
| Q3 2020 | -12.07% |
| Q2 2020 | 10.32% |
| Q1 2020 | -31.91% |
| Q4 2019 | 40.94% |
| Q3 2019 | -15.05% |
| Q2 2019 | 75.22% |
| Q1 2019 | -31.78% |
| Q4 2018 | 13.76% |
| Q3 2018 | 3.61% |
| Q2 2018 | -1.92% |
| Q1 2018 | -11.15% |
| Q4 2017 | 2.05% |
| Q3 2017 | 4.88% |
| Q2 2017 | -1.58% |
| Q1 2017 | 0.05% |
| Q4 2016 | 26.67% |
| Q3 2016 | -28.59% |
| Q2 2016 | 1.56% |
| Q1 2016 | 21.98% |
| Q4 2015 | 15.62% |